An independent intelligence board aggregating credible research, preprints, clinical findings, biohacking experiments, and community discussions on therapeutic peptides, longevity science, and evidence-based anti-aging. Stories are scored for relevance, credibility, novelty, momentum, and practicality so the most important findings surface first.
A Reddit user says they've been on Wegovy (a weight-loss drug) for seven months and aren't losing much weight. They're also dealing with persistent mild nausea that sometimes becomes a severe stomach problem. They're asking whether switching from Wegovy to Mounjaro (often called MJ) helped other people. The post is a request for personal experiences, not a scientific study. Wegovy is the brand name for semaglutide. Semaglutide copies a natural gut hormone that helps control appetite and digestion. In simple terms, it makes you feel fuller sooner and can slow how fast your stomach empties. Mounjaro is the brand name for tirzepatide. Tirzepatide acts on two hormone receptors instead of one — it mimics both the appetite-related gut hormone plus another that affects insulin and blood sugar. That dual action is why some people and doctors think it might lead to bigger weight loss for some patients. What the research shows so far is mixed but promising. Large clinical trials found that semaglutide and tirzepatide can produce meaningful weight loss on average when combined with diet and exercise. Tirzepatide often shows larger average weight loss than semaglutide in head-to-head trials, but those are controlled studies with many participants and specific dosing schedules. The Reddit post is just one person’s experience asking for anecdotes; it doesn't provide hard data. Individual responses vary a lot: some people lose a lot, some lose little or plateau, and side effects differ between drugs and individuals. Why this matters is practical: if you’re not getting the results you hoped for on one medication, it’s reasonable to ask whether another might work better. For people struggling with obesity, diabetes, or weight-related health issues, switching drugs could improve outcomes. But changing medications isn't just swapping bottles. Doctors consider your medical history, other medications, cost and insurance coverage, and how you tolerated side effects like nausea. Many people who switch see different levels of benefit, but there’s no guarantee one will be a clear fix for a non-responder. There are important caveats and risks. Both drugs can cause nausea, vomiting, diarrhea, constipation, and stomach discomfort; some people stop treatment because of these side effects. Rare but serious risks include pancreatitis (inflammation of the pancreas) and possible effects on the gallbladder. Long-term safety data are still accumulating, especially for newer uses and higher doses. Neither drug is over-the-counter — they require a prescription and medical monitoring. If someone is having severe gastrointestinal issues on their current drug, they should talk to their prescriber before switching or stopping. Insurance coverage and cost can also be major barriers. Bottom line: switching from Wegovy to Mounjaro is an option some people try and some studies suggest tirzepatide may lead to greater weight loss on average, but responses and side effects vary, so discuss it with your doctor rather than relying on anecdotes.
Source: r/Mounjaro